Orville G. Kolterman

Director/Board Member at American Diabetes Association Research Foundation, Inc.

76 year

Health Technology

Consumer Services

Government

Profile

Orville G.
Kolterman is currently a Director at the American Diabetes Association Research Foundation, Inc., GlySens, Inc., and a Member at the National Institute of Diabetes & Digestive & Kidney Diseases.
He was previously a Director at ViaCyte, Inc., the Medical Director-Diabetes Center at the University of California San Diego, Chief Medical Officer & Senior Vice President at Amylin Pharmaceuticals, Inc., and President at the American Diabetes Association.
He was also an Assistant Professor at The University of Colorado School of Medicine.
Dr. Kolterman holds a doctorate degree from Stanford University School of Medicine.

Orville G. Kolterman active positions

Companies	Position	Start
National Institute of Diabetes & Digestive & Kidney Diseases	Corporate Officer/Principal	-
GlySens, Inc. GlySens, Inc. Medical SpecialtiesHealth Technology GlySens, Inc. develops glucose monitoring system. It offers GlySens ICGM system, a long continuous glucose monitoring system intends to dramatically improve the lives of people with diabetes. The firm develops testing in clinical trials a novel, long term implant to continuously monitor and transmit blood glucose levels to smart phones and other devices. The company was founded by Joseph Y. Lucisano and David A. Gough in 1998 and is headquartered in San Diego, CA.	Director/Board Member	26/10/2011
American Diabetes Association Research Foundation, Inc.	Director/Board Member	26/10/2011

All active positions of Orville G. Kolterman

Former positions of Orville G. Kolterman

Companies	Position	End
ViaCyte, Inc. ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA.	Director/Board Member	28/01/2019
University of California San Diego	Corporate Officer/Principal	31/12/1991
The University of Colorado School of Medicine	Corporate Officer/Principal	31/12/1982
American Diabetes Association American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA.	President	-
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.	Chief Tech/Sci/R&D Officer	-

See the detail of Orville G. Kolterman's experience

Training of Orville G. Kolterman

Stanford University School of Medicine

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Orville G. Kolterman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA.	Health Technology
National Institute of Diabetes & Digestive & Kidney Diseases	Government
American Diabetes Association American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA.	Commercial Services
ViaCyte, Inc. ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA.	Health Technology
GlySens, Inc. GlySens, Inc. Medical SpecialtiesHealth Technology GlySens, Inc. develops glucose monitoring system. It offers GlySens ICGM system, a long continuous glucose monitoring system intends to dramatically improve the lives of people with diabetes. The firm develops testing in clinical trials a novel, long term implant to continuously monitor and transmit blood glucose levels to smart phones and other devices. The company was founded by Joseph Y. Lucisano and David A. Gough in 1998 and is headquartered in San Diego, CA.	Health Technology
American Diabetes Association Research Foundation, Inc.

See company connections